Department of Molecular Innovation in Lipidology

Member

Director	Mariko Harada-Shiba
Laboratory chief	Mika Hori, Masatsune Ogura
Staff scientist	Kota Matsuki
Postdoctoral fellow	Fumito Wada, Yumi Yamamoto, Masashi Yamamoto

Research Focus

We have been studying the mechanisms of dyslipidemia and atherosclerosis. Our goal is to develop new drugs for prevention and treatment of atherosclerosis based on our lipid research.

Genetic analysis for clarifying etiology and pathophysiology of dyslipidemia
Development of antisense drugs targeting dyslipidemia
Making guidelines of familial hypercholesterolemia
Development of novel therapy for atherosclerosis based on the evaluation of quality and quantity of HDL